PRIMARY SURGICAL THERAPY FOR BIOLOGICALLY DEFINED LOW-RISK NEUROBLASTOMA

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is closed to new enrollment. (Clinical trial summary from the National Cancer Institute's PDQ database) Surgery alone may be effective in treating children with neuroblastoma.This is a Phase III trial to study the effectiveness of surgery alone in treating children who have neuroblastoma. Patients will undergo surgery to remove the tumor and involved lymph nodes. Some patients may also receive combination chemotherapy, further surgery, and/or radiation therapy. Patients will receive follow-up evaluation